AL050-ABC / Alector - LARVOL DELTA

Alector Brain Carrier: Preclinical and Research Pipeline - AL050 (GlobeNewswire) - "Alector has selected lead candidate AL050 for its ABC-enabled glucocerebrosidase (GCase) enzyme replacement therapy (ERT) in Parkinson’s disease (PD) and is advancing the candidate toward IND-enabling studies. The company is targeting submission of an IND application for AL050 in 2027."

IND • Parkinson's Disease